Ursal, Kent B.
HRN: 22-41-36 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2023
CEFUROXIME 750MG (VIAL)
08/23/2023
08/30/2023
IV
216mg
TID
PCAP-C; AGE W/ Mod. Dehydration
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes